186 related articles for article (PubMed ID: 32441483)
41. Induction of experimental obstructive cholestasis in mice.
Tag CG; Weiskirchen S; Hittatiya K; Tacke F; Tolba RH; Weiskirchen R
Lab Anim; 2015 Apr; 49(1 Suppl):70-80. PubMed ID: 25835740
[TBL] [Abstract][Full Text] [Related]
42. Hepatic LGR4 aggravates cholestasis-induced liver injury in mice.
Gao Y; Zhai W; Sun L; Du X; Wang X; Mulholland MW; Yin Y; Zhang W
Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G460-G472. PubMed ID: 38440827
[TBL] [Abstract][Full Text] [Related]
43. Effect of bile duct obstruction on the expression of intestinal mRNA related to cholesterol and bile acid metabolism in the rat.
Kamisako T; Ogawa H
J Gastroenterol Hepatol; 2007 Jan; 22(1):125-31. PubMed ID: 17201892
[TBL] [Abstract][Full Text] [Related]
44. Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis.
Pan Q; Zhang X; Zhang L; Cheng Y; Zhao N; Li F; Zhou X; Chen S; Li J; Xu S; Huang D; Chen Y; Li L; Wang H; Chen W; Cai SY; Boyer JL; Chai J
Gastroenterology; 2018 Nov; 155(5):1578-1592.e16. PubMed ID: 30063921
[TBL] [Abstract][Full Text] [Related]
45. Protective effect of the aqueous extract from the root of Platycodon grandiflorum on cholestasis-induced hepatic injury in mice.
Kim TW; Lee HK; Song IB; Kim MS; Hwang YH; Lim JH; Park SJ; Lee SW; Kim JW; Yun HI
Pharm Biol; 2012 Dec; 50(12):1473-8. PubMed ID: 23035893
[TBL] [Abstract][Full Text] [Related]
46. Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease.
Blokker BA; Maijo M; Echeandia M; Galduroz M; Patterson AM; Ten A; Philo M; Schungel R; Gutierrez-de Juan V; Halilbasic E; Fuchs C; Le Gall G; Milkiewicz M; Milkiewicz P; Banales JM; Rushbrook SM; Mato JM; Trauner M; Müller M; Martínez-Chantar ML; Varela-Rey M; Beraza N
Hepatology; 2019 Feb; 69(2):699-716. PubMed ID: 30229970
[TBL] [Abstract][Full Text] [Related]
47. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity.
Ahmadi A; Niknahad H; Li H; Mobasheri A; Manthari RK; Azarpira N; Mousavi K; Khalvati B; Zhao Y; Sun J; Zong Y; Ommati MM; Heidari R
Toxicol Lett; 2021 Oct; 349():12-29. PubMed ID: 34089816
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic targets for cholestatic liver injury.
Woolbright BL; Jaeschke H
Expert Opin Ther Targets; 2016; 20(4):463-75. PubMed ID: 26479335
[TBL] [Abstract][Full Text] [Related]
49. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
[TBL] [Abstract][Full Text] [Related]
50. Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal Blood.
Ghallab A; Hofmann U; Sezgin S; Vartak N; Hassan R; Zaza A; Godoy P; Schneider KM; Guenther G; Ahmed YA; Abbas AA; Keitel V; Kuepfer L; Dooley S; Lammert F; Trautwein C; Spiteller M; Drasdo D; Hofmann AF; Jansen PLM; Hengstler JG; Reif R
Hepatology; 2019 Feb; 69(2):666-683. PubMed ID: 30102412
[TBL] [Abstract][Full Text] [Related]
51. C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice.
Liu R; Li X; Huang Z; Zhao D; Ganesh BS; Lai G; Pandak WM; Hylemon PB; Bajaj JS; Sanyal AJ; Zhou H
Hepatology; 2018 Apr; 67(4):1441-1457. PubMed ID: 28926118
[TBL] [Abstract][Full Text] [Related]
52. Protective effect of Urtica dioica on liver damage induced by biliary obstruction in rats.
Oguz S; Kanter M; Erboga M; Ibis C
Toxicol Ind Health; 2013 Oct; 29(9):838-45. PubMed ID: 22585933
[TBL] [Abstract][Full Text] [Related]
53. Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury.
Sommer J; Dorn C; Gäbele E; Bataille F; Freese K; Seitz T; Thasler WE; Büttner R; Weiskirchen R; Bosserhoff A; Hellerbrand C
Cells; 2020 Jan; 9(1):. PubMed ID: 31963815
[TBL] [Abstract][Full Text] [Related]
54. Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury.
Shearn CT; Anderson AL; Miller CG; Noyd RC; Devereaux MW; Balasubramaniyan N; Orlicky DJ; Schmidt EE; Sokol RJ
Hepatol Commun; 2023 Jan; 7(1):e0020. PubMed ID: 36633484
[TBL] [Abstract][Full Text] [Related]
55. NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism.
Cheng CW; Duwaerts CC; Rooijen Nv; Wintermeyer P; Mott S; Gregory SH
J Hepatol; 2011 Apr; 54(4):746-52. PubMed ID: 21129806
[TBL] [Abstract][Full Text] [Related]
56. Kupffer cells abrogate cholestatic liver injury in mice.
Gehring S; Dickson EM; San Martin ME; van Rooijen N; Papa EF; Harty MW; Tracy TF; Gregory SH
Gastroenterology; 2006 Mar; 130(3):810-22. PubMed ID: 16530521
[TBL] [Abstract][Full Text] [Related]
57. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis.
Park YJ; Qatanani M; Chua SS; LaRey JL; Johnson SA; Watanabe M; Moore DD; Lee YK
Hepatology; 2008 May; 47(5):1578-86. PubMed ID: 18393320
[TBL] [Abstract][Full Text] [Related]
58. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
[TBL] [Abstract][Full Text] [Related]
59. Nifuroxazide mitigates cholestatic liver injury by synergistic inhibition of Il-6/Β-catenin signaling and enhancement of BSEP and MDRP
Nazmy EA; Helal MG; Said E
Int Immunopharmacol; 2021 Oct; 99():107931. PubMed ID: 34247051
[TBL] [Abstract][Full Text] [Related]
60. Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice.
Rattay S; Graf D; Kislat A; Homey B; Herebian D; Häussinger D; Hengel H; Zimmermann A; Schupp AK
PLoS One; 2018; 13(6):e0199863. PubMed ID: 29953538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
